The company's primary investment objectives are to generate attractive current yields and risk-adjusted total returns by selecting investments expected to provide strong total return and sustainable earnings streams over a long-term horizon. The company takes a trading-oriented approach seeking to exploit pricing inefficiencies in the CLO market.
Cyborg Score Rationale
The company's NAV per share has declined 25% over the past year, and dividend coverage is currently adequate but net investment income below distributions indicates a dividend cut is likely. Operating cash flow may not be sufficient to safely service the company's debt.
Top Insights
Q4 FY 2026 (quarter ended March 31, 2026) reported NAV per share of $4.09 and GAAP net loss of $32.3 million or $(0.86) per share, though adjusted net investment income was $7.3 million
CLO portfolio reached $307.9 million fair value with a 12.5% GAAP yield and 16.6% projected yield as of March 2026
Launched ELLA, an 8.50% baby bond maturing in 2031 in 2026
Monthly common dividend of $0.08 per share declared for May 2026 and July 2026 payments
Named Competitors
Golub Capital BDC — Closed-end management company investing in CLOs and credit strategies
Ares Credit Opportunities — Global credit and CLO investor
Benefit Street Partners CLO Funds — Alternative asset manager specializing in CLO and credit investments
Recent Developments
(May 2026) Q4 FY 2026 results released showing $307.9M CLO portfolio and $4.09 NAV per share
(2026) Launched ELLA 8.50% baby bonds due 2031 and issued $54M of senior notes
(April 2024) Completed strategic rebranding from Ellington Residential Mortgage REIT to Ellington Credit Company
(June 2026) Maintained monthly dividend of $0.08 per share
Open the full interactive Ellington Credit Company report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.